Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Heart and Vessels|July 2, 2013
Impacts of age on coronary atherosclerosis and vascular response to statin therapyTsuyoshi Nozue, Shingo Yamamoto, Shinichi Tohyama, et al.
Heart and Vessels|March 4, 2016
Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched studyNorihiro Kobayashi, Yoshiaki Ito, Keisuke Hirano, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 8, 2014
Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXTTakashi Kubo, Takashi Akasaka, Ken Kozuma, et al.
Circulation. Cardiovascular Interventions|May 8, 2014
Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent TrialHiroki Shiomi, Ken Kozuma, Takeshi Morimoto, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 14, 2017
Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trialKengo Tanabe, Jeffrey J Popma, Ken Kozuma, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 30, 2018
Sex Differences in Long-Term Clinical Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Stent ImplantationYukiko Matsumura-Nakano, Hiroki Shiomi, Takeshi Morimoto, et al.
Journal of the American Heart Association|July 2, 2018
Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT TrialsHiroki Watanabe, Takeshi Morimoto, Hiroki Shiomi, et al.
European Heart Journal|September 3, 2015
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB JapanTakeshi Kimura, Ken Kozuma, Kengo Tanabe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 6, 2017
Second-Generation vs. First-Generation Drug-Eluting Stents in Patients With Calcified Coronary Lesions　- Pooled Analysis From the RESET and NEXT TrialsKoji Nishida, Kenji Nakatsuma, Hiroki Shiomi, et al.
Circulation|February 11, 2009
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantationTakeshi Kimura, Takeshi Morimoto, Yoshihisa Nakagawa, et al.
Pageof 13